These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1471201)

  • 1. Use of biomarkers in epidemiology: quantitative aspects.
    Ehrenberg L; Törnqvist M
    Toxicol Lett; 1992 Dec; 64-65 Spec No():485-92. PubMed ID: 1471201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemoglobin adducts for in vivo dose monitoring and cancer risk estimation.
    Törnqvist M; Landin HH
    J Occup Environ Med; 1995 Sep; 37(9):1077-85. PubMed ID: 8528715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macromolecule adducts as biomarkers of exposure to environmental mutagens in human populations.
    Ehrenberg L; Granath F; Törnqvist M
    Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):423-8. PubMed ID: 8781357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human health risk assessment and biological reactive intermediates: hemoglobin binding.
    Ehrenberg L; Tornqvist M
    Adv Exp Med Biol; 1991; 283():641-7. PubMed ID: 2069032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA adducts and chronic degenerative disease. Pathogenetic relevance and implications in preventive medicine.
    De Flora S; Izzotti A; Randerath K; Randerath E; Bartsch H; Nair J; Balansky R; van Schooten F; Degan P; Fronza G; Walsh D; Lewtas J
    Mutat Res; 1996 Dec; 366(3):197-238. PubMed ID: 9033668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mercapturic acids, protein adducts, and DNA adducts as biomarkers of electrophilic chemicals.
    van Welie RT; van Dijck RG; Vermeulen NP; van Sittert NJ
    Crit Rev Toxicol; 1992; 22(5-6):271-306. PubMed ID: 1489508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Covalent binding of genotoxic agents to proteins and nucleic acids.
    Ehrenberg L
    IARC Sci Publ; 1984; (59):107-14. PubMed ID: 6545273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure and Metabolic Activation Biomarkers of Carcinogenic Tobacco-Specific Nitrosamines.
    Hecht SS; Stepanov I; Carmella SG
    Acc Chem Res; 2016 Jan; 49(1):106-14. PubMed ID: 26678241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human biomonitoring: state of the art.
    Angerer J; Ewers U; Wilhelm M
    Int J Hyg Environ Health; 2007 May; 210(3-4):201-28. PubMed ID: 17376741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biomarkers of internal exposure to toxicologically relevant contaminants in food].
    Abraham K; Monien B; Lampen A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Jul; 60(7):761-767. PubMed ID: 28516258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular epidemiology in cancer risk assessment and prevention: recent progress and avenues for future research.
    Wogan GN
    Environ Health Perspect; 1992 Nov; 98():167-78. PubMed ID: 1486846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiology studies on occupational and environmental exposure to mutagens and carcinogens, 1997-1999.
    Srám RJ; Binková B
    Environ Health Perspect; 2000 Mar; 108 Suppl 1(Suppl 1):57-70. PubMed ID: 10698723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Search for unknown adducts: increase of sensitivity through preselection by biochemical parameters.
    Törnqvist M
    IARC Sci Publ; 1988; (89):378-83. PubMed ID: 3198224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alkylation of macromolecules for detecting mutagenic agents.
    Ehrenberg L; Osterman-Golkar S
    Teratog Carcinog Mutagen; 1980; 1(1):105-27. PubMed ID: 6119796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of DNA adducts to identify human health risk from exposure to hazardous environmental pollutants: the increasing role of mass spectrometry in assessing biologically effective doses of genotoxic carcinogens.
    Farmer PB; Singh R
    Mutat Res; 2008; 659(1-2):68-76. PubMed ID: 18468947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Qualitative and quantitative procedures for health risk assessment.
    Lohman PH
    Mutat Res; 1999 Jul; 428(1-2):237-54. PubMed ID: 10517997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future research directions to characterize environmental mutagens in highly polluted area.
    Srám RJ
    Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):603-7. PubMed ID: 8781390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LC-MS/MS screening strategy for unknown adducts to N-terminal valine in hemoglobin applied to smokers and nonsmokers.
    Carlsson H; von Stedingk H; Nilsson U; Törnqvist M
    Chem Res Toxicol; 2014 Dec; 27(12):2062-70. PubMed ID: 25350717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and molecular epidemiology of cancer.
    Sugimura H; Weston A; Caporaso NE; Shields PG; Bowman ED; Metcalf RA; Harris CC
    Biomed Environ Sci; 1991 Jun; 4(1-2):73-92. PubMed ID: 1910603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.